Skip to main content
Erschienen in: Journal of Clinical Immunology 7/2016

02.08.2016 | Original Article

Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital’s 5-Year Experience

verfasst von: Nermeen Galal, Safa Meshaal, Rabab Elhawary, Dalia Abd ElAziz, Radwa Alkady, Sohilla Lotfy, Alia Eldash, Jeanette Boutros, Aisha Elmarsafy

Erschienen in: Journal of Clinical Immunology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Primary immunodeficiency disorders (PIDs) are heterogeneous disorders that mainly present with severe, persistent, unusual, or recurrent infections in childhood. Reports from different parts of the world indicate a difference between Western and Eastern populations.

Aim

The aim of this study was to report on the different patterns of PIDs and identify subgroup characteristics in a highly consanguineous population in Egypt.

Methods

We performed a retrospective chart review for children below 18 years diagnosed with PID at Cairo University Pediatric Hospital from 2010 to 2014.

Results

Four hundred seventy-six children were diagnosed with PID disorders. Major categories included combined immunodeficiency disorders, which constituted a large proportion (30 %) of cases, along with predominantly antibody disorders (18 %) followed by syndromic combined disorders (16.8 %), phagocytic disorders (13.2 %), immune dysregulation disorders (10.5 %), and autoinflammatory disorders (9 %).

Conclusion

PIDs have different patterns within inbred populations with high consanguinity.
Literatur
1.
Zurück zum Zitat Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.CrossRefPubMed Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.CrossRefPubMed
2.
Zurück zum Zitat Al-Herz W, Aldhekri H, Barbouche MR, Rezaaei N. Consanguinity and primary immunodeficiencies. Hum Hered. 2014;77(1–4):138–43.CrossRefPubMed Al-Herz W, Aldhekri H, Barbouche MR, Rezaaei N. Consanguinity and primary immunodeficiencies. Hum Hered. 2014;77(1–4):138–43.CrossRefPubMed
3.
Zurück zum Zitat Shawky RM, ElAwady M, Elsayed S, Hamadan G. Consanguinous matings among Egyptian population. Egypt J Med Hum Genet. 2012;12(2):157–63.CrossRef Shawky RM, ElAwady M, Elsayed S, Hamadan G. Consanguinous matings among Egyptian population. Egypt J Med Hum Genet. 2012;12(2):157–63.CrossRef
4.
Zurück zum Zitat Temtamy S, Aglan M. Consanguinity and genetic disorders in Egypt. Middle East J Med Genet. 2011;1(1):12–7.CrossRef Temtamy S, Aglan M. Consanguinity and genetic disorders in Egypt. Middle East J Med Genet. 2011;1(1):12–7.CrossRef
5.
Zurück zum Zitat Anwar WA, Khayatti M, Hemminki K. Consanguinity and genetic diseases in North Africa and immigrants to Europe. Eur J Public Health. 2014;24 Suppl 1:57–63.CrossRefPubMed Anwar WA, Khayatti M, Hemminki K. Consanguinity and genetic diseases in North Africa and immigrants to Europe. Eur J Public Health. 2014;24 Suppl 1:57–63.CrossRefPubMed
6.
Zurück zum Zitat Bashamboo A, McElreavey K. Consanguinity and disorders of sex development. Hum Hered. 2014;77(1–4):108–17.CrossRefPubMed Bashamboo A, McElreavey K. Consanguinity and disorders of sex development. Hum Hered. 2014;77(1–4):108–17.CrossRefPubMed
7.
Zurück zum Zitat Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726.CrossRefPubMedPubMedCentral Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Meshaal S., El Hawary R., Elsharkawy M., Mousa R., Farid R., Abd. Elaziz D, Alkady R, Galal N., Massaad M, Boutros J., El Marsafy A. Mutations in recombination activating gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt. Clin Immunol. 2015; 158: 167–172 Meshaal S., El Hawary R., Elsharkawy M., Mousa R., Farid R., Abd. Elaziz D, Alkady R, Galal N., Massaad M, Boutros J., El Marsafy A. Mutations in recombination activating gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt. Clin Immunol. 2015; 158: 167–172
9.
Zurück zum Zitat Al-Saud B, Al-Mousa H, Al Gazlan S, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35(7):651–60.CrossRefPubMed Al-Saud B, Al-Mousa H, Al Gazlan S, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35(7):651–60.CrossRefPubMed
10.
Zurück zum Zitat Azarsiz E, Gulez N, Karaca NE, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis inTurkish patients with combined immunodeficiencies: a single center study. J Clin Immunol. 2011;31:106–11.CrossRefPubMed Azarsiz E, Gulez N, Karaca NE, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis inTurkish patients with combined immunodeficiencies: a single center study. J Clin Immunol. 2011;31:106–11.CrossRefPubMed
11.
Zurück zum Zitat Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988–2012). J Clin Immunol. 2015;35(8):745–53.CrossRefPubMed Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988–2012). J Clin Immunol. 2015;35(8):745–53.CrossRefPubMed
12.
Zurück zum Zitat Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34:459–68.PubMed Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34:459–68.PubMed
13.
Zurück zum Zitat Al –Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry. J Clin Immunol. 2008;28(2):186–93.CrossRefPubMed Al –Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry. J Clin Immunol. 2008;28(2):186–93.CrossRefPubMed
14.
Zurück zum Zitat Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, et al. Defects along the Th17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol. 2009;124(2):342–8.CrossRefPubMed Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, et al. Defects along the Th17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol. 2009;124(2):342–8.CrossRefPubMed
15.
Zurück zum Zitat Kilic S, Ozel M, Hafizoglu D, Karaca NE, Asku G, Kutukculer N. The prevalence and patient characteristics of primary immunodeficiency diseases in Turkey—two centers study. J Clin Immunol. 2013;33:74–83.CrossRefPubMed Kilic S, Ozel M, Hafizoglu D, Karaca NE, Asku G, Kutukculer N. The prevalence and patient characteristics of primary immunodeficiency diseases in Turkey—two centers study. J Clin Immunol. 2013;33:74–83.CrossRefPubMed
16.
Zurück zum Zitat Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–63.CrossRefPubMed Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–63.CrossRefPubMed
17.
Zurück zum Zitat Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. World Allergy Organ J. 2012;5(5):52–6.CrossRefPubMedPubMedCentral Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. World Allergy Organ J. 2012;5(5):52–6.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343–51.CrossRefPubMed Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343–51.CrossRefPubMed
19.
Zurück zum Zitat Al-Herz W, Notarangelo LD, Sadek A, Buckley R, USIDNET Consortium. Combined Immunodeficiency in the United States and Kuwait: comparison of patients’characteristics and molecular diagnosis. Clin Immunol. 2015;161(2):170–3.CrossRefPubMedPubMedCentral Al-Herz W, Notarangelo LD, Sadek A, Buckley R, USIDNET Consortium. Combined Immunodeficiency in the United States and Kuwait: comparison of patients’characteristics and molecular diagnosis. Clin Immunol. 2015;161(2):170–3.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Wolach B, Gavrieli R, de Boer M, Gottesman G, Ben-Ari J, Rottem M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103–14.CrossRefPubMed Wolach B, Gavrieli R, de Boer M, Gottesman G, Ben-Ari J, Rottem M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103–14.CrossRefPubMed
21.
Zurück zum Zitat Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: Two decades of experience from a tertiary care center in North West India. J Clin Immunol. 2014;34(1):58–67.CrossRefPubMed Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: Two decades of experience from a tertiary care center in North West India. J Clin Immunol. 2014;34(1):58–67.CrossRefPubMed
22.
Zurück zum Zitat Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.CrossRef Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.CrossRef
23.
Zurück zum Zitat Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.CrossRefPubMedPubMedCentral Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat El-Garf A, Salah S, Iskander I, Salah H, Amin SN. MEFV mutations in Egyptian patients suffering from familial Mediterranean fever analysis of 12 gene mutations. Rheumatol Int. 2010;30(10):1293–8.CrossRefPubMed El-Garf A, Salah S, Iskander I, Salah H, Amin SN. MEFV mutations in Egyptian patients suffering from familial Mediterranean fever analysis of 12 gene mutations. Rheumatol Int. 2010;30(10):1293–8.CrossRefPubMed
25.
Zurück zum Zitat Galal N, Boutros J, Marsafy A, Kong XF, Feinberg J, Casanova JL, et al. Mendelian susceptibility to mycobacterial disease in Egyptian children. Mediterr J Hematol Infect Dis. 2012;4(1), e2012033.CrossRefPubMedPubMedCentral Galal N, Boutros J, Marsafy A, Kong XF, Feinberg J, Casanova JL, et al. Mendelian susceptibility to mycobacterial disease in Egyptian children. Mediterr J Hematol Infect Dis. 2012;4(1), e2012033.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Elloumi-Zghal H, Barbouche MR, Chemli J, Bejaoui M, Harbi A, Snoussi N, et al. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis Bacille Calmette-Guérin infection. J Infect Dis. 2002;185:1468–75.CrossRefPubMed Elloumi-Zghal H, Barbouche MR, Chemli J, Bejaoui M, Harbi A, Snoussi N, et al. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis Bacille Calmette-Guérin infection. J Infect Dis. 2002;185:1468–75.CrossRefPubMed
Metadaten
Titel
Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital’s 5-Year Experience
verfasst von
Nermeen Galal
Safa Meshaal
Rabab Elhawary
Dalia Abd ElAziz
Radwa Alkady
Sohilla Lotfy
Alia Eldash
Jeanette Boutros
Aisha Elmarsafy
Publikationsdatum
02.08.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 7/2016
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0314-1

Weitere Artikel der Ausgabe 7/2016

Journal of Clinical Immunology 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.